keyword
https://read.qxmd.com/read/38648863/linzagolix-therapy-versus-a-placebo-in-patients-with-endometriosis-associated-pain-a-prospective-randomized-double-blind-phase-3-study-edelweiss-3
#1
JOURNAL ARTICLE
Jacques Donnez, Christian Becker, Hugh Taylor, Francisco Carmona Herrera, Olivier Donnez, Andrew Horne, Maciej Paszkowski, Felice Petraglia, Stefan P Renner, Amisha Patel, Mitra Boolell, Elke Bestel, Marie-Madeleine Dolmans
STUDY QUESTION: Does linzagolix administered orally once daily for up to 3 months at a dose of 75 mg alone or 200 mg in combination with add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethindrone acetate, also known as norethisterone acetate [NETA]) demonstrate better efficacy than placebo in the management of endometriosis-related dysmenorrhea and non-menstrual pelvic pain? SUMMARY ANSWER: Combining 200 mg linzagolix with ABT was found to significantly reduce dysmenorrhea and non-menstrual pelvic pain at 3 months of therapy, while a daily dose of 75 mg linzagolix yielded a significant decrease only in dysmenorrhea at 3 months...
April 22, 2024: Human Reproduction
https://read.qxmd.com/read/38644275/-analysis-of-related-factors-influencing-the-detection-rate-of-mosaic-embryo-and-the-pregnancy-outcomes-with-mosaic-embryo-transfers
#2
JOURNAL ARTICLE
Q Zhang, S Xiong, W Han, D Y Liu, G N Huang, T T Lin
Objective: To explore the related factors influencing the detection rate of mosaic embryo and the pregnancy outcomes of mosaic embryo transfer in preimplantation genetic testing for aneuploidy (PGT-A) based on next generation sequencing (NGS) technology. Methods: A retrospective study was performed to analyze the clinical data of patients in 745 PGT-A cycles from January 2019 to May 2023 at Chongqing Health Center for Women and Children, including 2 850 blastocysts. The biopsy cells were tested using NGS technology, and the embryos were divided into three groups based on the test results, namely euploid embryos, aneuploid embryos and mosaic embryos...
April 25, 2024: Zhonghua Fu Chan Ke za Zhi
https://read.qxmd.com/read/38642365/combined-first-trimester-screening-and-invasive-diagnostics-for-atypical-chromosomal-aberrations-danish-nationwide-data-on-prenatal-profiles-and-detection-compared-with-nipt
#3
JOURNAL ARTICLE
K Gadsbøll, I Vogel, S E Kristensen, L H Pedersen, J Hyett, O B Petersen
OBJECTIVE: To examine the prenatal profiles of pregnancies affected by an atypical chromosomal aberration, focusing on pathogenic copy number variants (pCNVs). Further, we wanted to quantify the performance of combined first-trimester screening (cFTS) and a second-trimester anomaly scan in detecting these conditions. Finally, we aimed to estimate the consequences of a policy of using non-invasive prenatal testing (NIPT) rather than invasive testing with chromosomal microarray (CMA) to manage pregnancies identified as high risk from cFTS...
April 20, 2024: Ultrasound in Obstetrics & Gynecology
https://read.qxmd.com/read/38633734/evaluation-of-the-effect-of-nigella-sativa-oil-on-the-outcome-of-missed-abortion-in-women-a-randomized-double-blind-clinical-trial
#4
JOURNAL ARTICLE
Belgheis Mohammadi, Leila Nazari Robati, Zeinab Tavakol, Mina Movahhed
BACKGROUND AND AIM: Due to the concern about the side effects of chemical drugs and their ineffectiveness, the use of natural compounds as alternatives or complementary therapies has received increasing attention. The purpose of this study was to investigate the effect of Nigella sativa oil on the outcome of missed abortion. METHODS: In this double-blind clinical trial, 70 nulliparous pregnant women referred to Hajar Hospital and Imam Ali clinics of Shahrekord and had missed abortion before the 12-week gestational age were selected and randomly divided into two interventions and control groups...
April 2024: Health Science Reports
https://read.qxmd.com/read/38629685/a-systematic-review-of-the-gonadotoxicity-of-osteosarcoma-and-ewing-s-sarcoma-chemotherapies-in-postpubertal-females-and-males
#5
REVIEW
Susanna Weidlinger, Satu Graber, Irina Bratschi, Janna Pape, Attila Kollár, Tanya Karrer, Michael von Wolff
Data on gonadotoxicity of chemotherapies are essential to better counsel young females and males about the risk of infertility and to better indicate fertility preservation measures before cancer therapies. However, such data have not recently been reviewed for bone cancer. Therefore, a systematic literature search was conducted considering papers published since 2000. This study is part of the FertiTOX® project, which aims to improve the lack of data regarding gonadotoxicity of cancer therapies to enable more accurate counseling regarding fertility preservation...
April 17, 2024: Journal of Adolescent and Young Adult Oncology
https://read.qxmd.com/read/38625811/associations-of-serum-perfluoroalkyl-substances-and-placental-human-chorionic-gonadotropin-in-early-pregnancy-measured-in-the-upside-study-in-rochester-new-york
#6
JOURNAL ARTICLE
Hai-Wei Liang, Hannu Koistinen, Emily S Barrett, Xiaoshuang Xun, Qing Yin, Kurunthachalam Kannan, Nora K Moog, Carla Ng, Thomas G O'Connor, Rich Miller, Jennifer J Adibi
BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are widely detected in pregnant women and associated with adverse outcomes related to impaired placental function. Human chorionic gonadotropin (hCG) is a dimeric glycoprotein hormone that can indicate placental toxicity. OBJECTIVES: Our aim was to quantify the association of serum PFAS with placental hCG, measured as an intact molecule (hCG), as free alpha-(<mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mtext>hCG</mml:mtext><mml:mi>α</mml:mi></mml:mrow></mml:math>) and beta-subunits (<mml:math xmlns:mml="https://www...
April 2024: Environmental Health Perspectives
https://read.qxmd.com/read/38617407/mathematical-study-of-polycystic-ovarian-syndrome-disease-including-medication-treatment-mechanism-for-infertility-in-women
#7
JOURNAL ARTICLE
Maryam Batool, Muhammad Farman, Aqeel Ahmad, Kottakkaran Sooppy Nisar
Among women of reproductive age, PCOS (polycystic ovarian syndrome) is one of the most prevalent endocrine illnesses. In addition to decreasing female fertility, this condition raises the risk of cardiovascular disease, diabetes, dyslipidemia, obesity, psychiatric disorders and other illnesses. In this paper, we constructed a fractional order model for polycystic ovarian syndrome by using a novel approach with the memory effect of a fractional operator. The study population was divided into four groups for this reason: Women who are at risk for infertility, PCOS sufferers, infertile women receiving therapy (gonadotropin and clomiphene citrate), and improved infertile women...
2024: AIMS Public Health
https://read.qxmd.com/read/38595887/comparative-management-methods-for-adolescents-with-polycystic-ovarian-syndrome-a-systemic-review
#8
REVIEW
Roberta L Vadan, Nanette Varela, Nikita Zhuravko, Noreena O Ogidan, Victor O Adedara, Emmanuel Keku
Polycystic ovarian syndrome (PCOS) is a common endocrinological disorder affecting many adolescents and women of reproductive age worldwide. A diagnosis of PCOS in adolescence relies upon investigating each medical history independently and noting commonly associated symptoms, including obesity, insulin resistance, acne, menstrual abnormalities, and hirsutism. Many researchers are aiming to discover a methodology to help manage the symptoms associated with PCOS, especially in adolescents. This review will investigate management methods possible for adolescents with PCOS...
March 2024: Curēus
https://read.qxmd.com/read/38593267/bioequivalence-of-elagolix-estradiol-norethindrone-acetate-fixed-dose-combination-product-phase-1-results-in-healthy-pre-and-postmenopausal-women
#9
JOURNAL ARTICLE
Mong-Jen Chen, Patrick Marroum, Yi-Lin Chiu, Melina Neenan, Nael M Mostafa, Mohamad Shebley
Fixed-dose combination (FDC) therapies can enhance patient convenience and adherence to prescribed treatment regimens. Elagolix is a novel oral gonadotropin-releasing hormone receptor antagonist approved for management of moderate to severe pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids. Hormonal add-back therapy can attenuate the reversible hypoestrogenic effects of elagolix. An FDC formulation containing elagolix/estradiol (E2)/norethindrone acetate (NETA) 300/1/0...
April 9, 2024: Clinical Pharmacology in Drug Development
https://read.qxmd.com/read/38592603/relugolix-estradiol-norethisterone-acetate-a-review-in-endometriosis-associated-pain
#10
JOURNAL ARTICLE
Hannah A Blair
An oral fixed-dose combination of relugolix/estradiol/norethisterone (also known as norethindrone) acetate [Myfembree® (USA); Ryeqo® (EU)] (hereafter referred to as relugolix combination therapy) has been approved in the USA for the management of moderate to severe pain associated with endometriosis in premenopausal women and in the EU for the symptomatic treatment of endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis. The gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix decreases estradiol and progesterone levels, while the addition of estradiol/norethisterone acetate mitigates hypoestrogenic effects including bone mineral density (BMD) loss and vasomotor symptoms...
April 9, 2024: Drugs
https://read.qxmd.com/read/38590512/-s-s-adenosylmethionine-in-the-treatment-of-pre-menstrual-disorders-in-adult-women-a-protocol-for-an-open-label-pilot-study
#11
JOURNAL ARTICLE
Brendan Stevenson, Emorfia Gavrilidis, Yasmin Malik, Jayashri Kulkarni
Pre-menstrual disorders, including pre-menstrual syndrome and pre-menstrual dysphoric disorder, are highly prevalent disorders in women of reproductive age. Pre-menstrual disorders are associated with debilitating symptoms that onset in the days prior to menses. A complex interplay between hormonal fluctuations, cellular sensitivity, and psychosocial stressors likely underly the pathophysiology of pre-menstrual disorders. Current treatment options include selective serotonin reuptake inhibitors, hormonal therapies, and psychosocial support...
June 2024: Contemporary Clinical Trials Communications
https://read.qxmd.com/read/38589892/mitigation-of-letrozole-induced-polycystic-ovarian-syndrome-associated-inflammatory-response-and-endocrinal-dysfunction-by-vitex-negundo-seeds
#12
JOURNAL ARTICLE
Tarun Kumar Kar, Sananda Sil, Angshita Ghosh, Ananya Barman, Sandip Chattopadhyay
BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder in women that necessitates effective and safe treatment alternatives. This study aimed to evaluate the therapeutic efficacy of Vitex negundo seed in a letrozole-induced PCOS rat model. RESULTS: Findings of the present study demonstrated that administration of hydro-ethanolic extract of Vitex negundo (VNE) effectively restored endocrino-metabolic imbalances associated with PCOS, along with correction of antioxidant enzymes level, proinflammatory cytokines, and apoptotic bio-markers...
April 8, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38589425/mechanism-of-elevated-lh-fsh-ratio-in-lean-pcos-revisited-a-path-analysis
#13
JOURNAL ARTICLE
Gita Pratama, Budi Wiweko, Asmarinah, Indah S Widyahening, Trinovita Andraini, Hartanto Bayuaji, Andon Hestiantoro
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting 5-20% of reproductive-age women. However, the treatment of PCOS is mainly based on symptoms and not on its pathophysiology. Neuroendocrine disturbance, as shown by an elevated LH/FSH ratio in PCOS patients, was thought to be the central mechanism of the syndrome, especially in lean PCOS. LH and FSH secretion are influenced by GnRH pulsatility of GnRH neurons in the hypothalamus. Kisspeptin is the main regulator of GnRH secretion, whereas neurokinin B (NKB) and dynorphin regulate kisspeptin secretion in KNDy neurons...
April 8, 2024: Scientific Reports
https://read.qxmd.com/read/38589241/chronic-interstitial-ectopic-pregnancy-presenting-with-a-negative-urine-pregnancy-test
#14
JOURNAL ARTICLE
Apiwat Jongjakapun, Lingling Salang, Apiwat Aueaungkul, Pilaiwan Kleebkaow
The ampulla portion of the fallopian tube is the most common site of ectopic pregnancy (70%), with approximately 2% of pregnancies implanted in the interstitial portion. In general, an interstitial ectopic pregnancy (IEP) is difficult to diagnose and is associated with a high rate of complications-most patients with an IEP present with severe abdominal pain and haemorrhagic shock due to an ectopic rupture. Chronic tubal pregnancy (CTP) is an uncommon condition with an incidence of 20%. The CTP has a longer clinical course and a negative or low level of serum beta-human chorionic gonadotropin due to perished chorionic villi...
April 8, 2024: BMJ Case Reports
https://read.qxmd.com/read/38584798/menstrual-abnormalities-effects-on-clinical-features-and-in-vitro-fertilization-pregnancy-outcomes-in-women-with-polycystic-ovarian-syndrome
#15
JOURNAL ARTICLE
Haozhe Miao, Huiming Yang, Mengfei Yin, Yixuan Wang, Yuan Fang, Min Yang, Jialin Zou, Wenwen Zhang, Lingling Zhang, Chendan Liu, Yue Wang, Ze Wang, Yunhai Yu, Daimin Wei
BACKGROUND: The diagnostic criteria and phenotypes in polycystic ovary syndrome are heterogeneous. Currently, it is unclear how to assess a patient's prognosis based on the onset time of menstruation disturbance. Evidence on this topic is scarce and has mainly focused on menstrual patterns. OBJECTIVE: This study aimed to assess the association between the onset time of menstrual disturbance and clinical features and in vitro fertilization pregnancy outcomes in patients with polycystic ovary syndrome...
May 2024: AJOG global reports
https://read.qxmd.com/read/38576003/enhancing-endometrial-receptivity-the-roles-of-human-chorionic-gonadotropin-in-autophagy-and-apoptosis-regulation-in-endometrial-stromal-cells
#16
JOURNAL ARTICLE
Bin Wang, Mingxia Gao, Ying Yao, Haofei Shen, Hongwei Li, Jingjing Sun, Liyan Wang, Xuehong Zhang
Inadequate endometrial receptivity often results in embryo implantation failure and miscarriage. Human chorionic gonadotropin (hCG) is a key signaling molecule secreted during early embryonic development, which regulates embryonic maternal interface signaling and promotes embryo implantation. This study aimed to examine the impact of hCG on endometrial receptivity and its underlying mechanisms. An exploratory study was designed, and endometrial samples were obtained from women diagnosed with simple tubal infertility or male factor infertile (n = 12) and recurrent implantation failure (RIF, n = 10)...
April 4, 2024: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/38575880/systematic-review-and-meta-analysis-on-the-effect-of-adjuvant-gonadotropin-releasing-hormone-agonist-gnrh-a-on-pregnancy-outcomes-in-women-with-endometriosis-following-conservative-surgery
#17
JOURNAL ARTICLE
Xuemei Qing, Lele He, Ying Ma, Yong Zhang, Wenxin Zheng
BACKGROUND: Endometriosis frequently results in pain and infertility. While conservative surgery offers some relief, it often falls short of ensuring satisfactory pregnancy outcomes. Adjuvant GnRH-a is administered post-surgery to mitigate recurrence; however, its impact on pregnancy outcomes remains debated. This study endeavors to assess the efficacy of adjuvant GnRH-a in enhancing pregnancy outcomes post-conservative surgery in endometriosis patients. METHODS: Databases including PubMed, Embase, the Cochrane Library, Medline (Ovid), Web of Science, and Scopus were rigorously searched up to 02 August 2023, without linguistic constraints...
April 4, 2024: BMC Pregnancy and Childbirth
https://read.qxmd.com/read/38570732/sex-steroid-levels-in-women-with-hypopituitarism-a-case-controlled-observational-study
#18
JOURNAL ARTICLE
Catharina Olivius, Kerstin Landin-Wilhelmsen, Claes Ohlsson, Matti Poutanen, Penelope Trimpou, Daniel S Olsson, Gudmundur Johannsson, Åsa Tivesten
CONTEXT: Women with hypopituitarism remain at increased risk of morbidity and mortality. Insufficient replacement of sex steroids has been suggested as a contributing factor, but sex steroid levels in women with hypopituitarism have not been comprehensively mapped. OBJECTIVE: To quantify sex steroids in women with hypopituitarism by a high-sensitivity assay. METHODS: Using a combination of clinical and biochemical criteria, women with hypopituitarism (n = 104) who started growth hormone replacement 1995-2014 at a single center were categorized as eugonadal or having hypogonadotropic hypogonadism (HH)...
April 4, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38566172/reproductive-outcomes-of-dual-trigger-therapy-with-gnrh-agonist-and-hcg-versus-hcg-trigger-in-women-with-diminished-ovarian-reserve-a-retrospective-study
#19
JOURNAL ARTICLE
Kai Chen, Chunmei Zhang, Lixue Chen, Yue Zhao, Hongzhen Li
BACKGROUND: Diminished ovarian reserve (DOR) is one of the obstacles affecting the reproductive outcomes of patients receiving assisted reproductive therapy. The purpose of this study was to investigate whether dual trigger, including gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG), can improve pregnancy outcomes in patients with DOR undergoing in vitro fertilization (IVF) cycles using mild stimulation protocols. METHODS: A total of 734 patients with DOR were included in this retrospective study...
April 2, 2024: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/38549926/the-fertility-sparing-treatment-and-outcome-of-epithelioid-trophoblastic-tumor-isolated-to-lung-a-case-report-and-review-literature
#20
Zengshu Huang, Yingjuan Yu, Darong Wen, Nan Wang, Liping Zeng
BACKGROUND: Epithelioid trophoblastic tumor (ETT) is the rarest gestational trophoblastic tumor, with poor response to chemotherapy. Hysterectomy, as the cornerstone therapy for early ETT, is particularly challenging in reproductive-age women who often have a strong desire for fertility preservation. The management of extra-uterine ETT could be even more complicated and inconsistent. Here we reported a case of isolated ETT lesions in lungs managed with thoracic surgery without hysterectomy...
2024: Frontiers in Oncology
keyword
keyword
93966
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.